vimarsana.com

Latest Breaking News On - United states national cancer institute - Page 8 : vimarsana.com

FemTech Company MobileODT awarded prestigious National Cancer Institute (NCI) grant

Share this article Share this article TEL AVIV, Israel, Jan. 20, 2021 /PRNewswire/ MobileODT, a FemTech company producing the latest digital innovation in cervical screening, has been awarded a prestigious Small Business Innovation Research Authority grant of $2.3 million. This grant is presented by the United States National Cancer Institute (NCI) to leading companies that are technologically and clinically advanced to support the NCI s goal of reducing suffering and death due to cancer. This grant is a tribute to the groundbreaking advances of MobileODT as an innovative company commercializing a novel cervical cancer screening technology utilizing complex machine learning (ML) and artificial intelligence (AI) algorithms. The company s technology offers an alternative screening modality to the current standard-of-care with significantly improved accuracy. It allows for a broader range of physicians, to perform cervical cancer screening, while defining the actual status of the pa

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.